Lipoprotein(a) as a risk factor associated with ischemic heart disease: Ouro Preto Study

Atherosclerosis

Volumn 191, Issue 2, 2007, Pages 454-459

  Cândido, Ana Paula Carlos ^a   Ferreira, Silvania ^a   Lima, Angélica Alves ^a   Nicolato, Roney Luiz de Carvalho ^a   Freitas, Sílvia Nascimento de ^a   Brandão, Paulo ^a   Pereira, Alexandre ^b   Krieger, José Eduardo ^b   Nascimento Neto, Raimundo Marques do ^c   Machado Coelho, George Luiz Lins ^a  

^a FEDERAL UNIVERSITY OF OURO PRETO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c Instituto de Hipertensão Arterial   (Brazil)

Author keywords

Cardiovascular risk factors; Ischemic heart disease; Lipoprotein(a); Obesity

Indexed keywords

LIPOPROTEIN A;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY FAT; BRAZIL; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL FEATURE; COHORT ANALYSIS; DISEASE ASSOCIATION; EVALUATION; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH SURVEY; HUMAN; IMPEDANCE; ISCHEMIC HEART DISEASE; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL LITERATURE; POPULATION RESEARCH; PRIORITY JOURNAL; RISK FACTOR; SEX RATIO; STATISTICAL ANALYSIS;

EID: 33947194225     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2006.04.031     Document Type: Article

References (32)

1. OPAS (Organización Panamericana de la Salud). Tendencias demográficas y de mortalidad en la región de las Américas, 1980-2000. Bol Epidemiol 23 3 (2002) 1-4
2. Armaganijan D., and Batlouni M. Impacto dos fatores de risco tradicionais. Rev Soc Cardiol Estado de São Paulo 10 6 (2000) 686-693
3. Harjai K.J. Potencial new cardiovascular risk factors: left ventricular hypertrophy, homocysteine, lipoprotein(a), triglycerides, oxidative stress and fibrinogen. Ann Intern Med 131 (1999) 376-386
4. Koschinsky M.L., and Marcovina S.M. Structure-function relationships in apolipoprotein (a): insights into lipoprotein(a) assembly and pathogenicity. Curr Opin Lipidol 15 2 (2004) 167-174
5. Koschinsky M.L., and Marcovina S.M. Evaluation of lipoprotein(a) as a prothrombotic factor: progress from bench to bedside. Curr Opin Lipidol 14 4 (2003) 361-366
6. Anglés-Cano E. Structural basis for the pathophysiology of lipoprotein (a) in the athero-thrombotic process. Braz J Med Biol Res 30 (1997) 1271-1280
7. Catalano M., Perilli E., Carzaniga G., et al. Lp(a) in hypertensive patients. J Hum Hypertens 12 (1998) 83-89
8. Gazzaruso C., Bruno R., Pujia A., et al. Lipoprotein(a), apolipoprotein(a) polymorphism and coronary atherosclerosis severity in type 2 diabetic patients. Int J Cardiol 108 3 (2006) 354-358
9. Habib S.S., and Aslam M. Lipids and lipoprotein(a) concentrations in Pakistani patients with type 2 diabetes mellitus. Diab Obes Metab 6 (2004) 338-343
10. Boyer H., Gennes J.L., Truffert J., et al. Lp(a) levels in different types of dyslipidemia in the French population. Atherosclerosis 85 (1990) 61-69
11. Wang J., Zhang C., Chen D., Liu X., and Feng X. Lipoprotein (a) and its immune complexes in dyslipidemic subjects. Clin Biochem 37 (2004) 710-713
12. Lamon-Fava S., Wilson P., and Schaefer E.J. Impact of body mass index on coronary heart disease risk factors in men and women. Arterioscler Thromb Vasc Biol 16 (1996) 1509-1515
13. Chien K.-L., Lee Y.-T., Sung F.-C., et al. Lipoprotein (a) level in the population in Taiwan: relationship to sociodemographic and atherosclerotic risk factors. Atherosclerosis 143 (1999) 267-273
14. Akanji A., Al-Shayji I., and Kumar P. Metabolic and anthropometric determinants of serum Lp(a) concentrations and apo(a) polymorphism in a healthy Arab population. Int J Obes 23 (1999) 855-862
15. IBGE (Instituto Brasileiro de Geografia e Estatística). Contagem populacional (1996)
16. Mion Júnior D. (Coord.). IV Diretrizes Brasileiras de Hipertensão Arterial. Sociedade Brasileira de Hipertensão, Sociedade Brasileira de Cardiologia, Sociedade Brasileira de Nefrologia. http://publicacoes.cardiol.br/consenso/2004/Diretriz%20HA%20ENG.pdf; September 2002.
17. World Health Organization. WHO Expert Committee on Physical Status: the use and interpretation of anthropometry physical status (1995), World Health Organization, Geneva [WHO Technical Report Series, vol. 854]
18. Han T.S., Van Leer E.M., Seidell J.C., and Lean M.E.J. Waist circumference action levels in the identification of cardiovascular risk factors: prevalence study in a random sample. BMJ 311 (1995) 1401-1405
19. Pereira R.A., Sichieri R., and Marins V.M.R. Razão cintura/quadril como preditor de hipertensão arterial. Cad Saúde Pública 15 2 (1999) 333-344
20. Gallagher D., Heymsfield S.B., Heo M., et al. Healthy percentage body fat ranges: an approach for developing guidelines based on body mass index. Am J Clin Nutr 72 (2000) 694-701
21. Instruction manual body fat monitor Omron BF 300, available at http://www.omron-healthcare.com/ [accessed on 20/03/2003].
22. National Institutes of Health Third Report of the National Cholesterol Education Program. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). National Cholesterol Education Program. National Heart, Lung, and Blood Institute. National Institutes of Health. Washington DC, US. NHI Publication. 01-3670; 2001. http://www.nhlbi.nih.gov/guidelines/cholesterol/atp3full.pdf (March 25, 2000).
23. Sociedade Brasileira de Diabetes Consenso Brasileiro de Conceitos e Condutas para o Diabetes Mellitus Recomendação da Sociedade Brasileira de Diabetes para a Prática Clínica. Federação Internacional de Diabetes/Associação para a América do Sul e Caribe October; 2000. http://www.anad.org.br/consenso.htm (May 12, 2001).
24. Leino A., Impivaara O., Kaitsaari M., and Järvisalo J. Serum concentrations of apolipoprotein A-1, Apolipoprotein B and lipoprotein(a) in a population sample. Clin Chem 41 (1995) 1633-1636
25. Utermann G. Genetic architecture and evolution of the lipoprotein(a) trait. Curr Opin Lipidol 10 (1999) 133-141
26. Frankenfield D.C., Rowe W.A., Cooney R.N., Smith J.S., and Becker D. Limits of body mass index to detect obesity and predict body composition. Nutrition 17 (2001) 26-33
27. Després J.P. The insulin resistance-dyslipidemic syndrome of visceral obesity: effect on patients' risk. Obes Res 6 (1998) 8-17
28. Sattar N., Tan C., Han T., et al. Associations of indices of adiposity with atherogenic lipoprotein subfractions. Int J Obes 22 (1998) 432-439
29. Sanz E.J., Cazurro A.M., Bellido A.L., and Martin I.M.L. Cigarette consumption and lipoprotein(a) concentrations. Clin Chem 42 (1996) 479
30. Agewall S., and Fagerberg B. Lipoprotein (a) was an independent predictor for major coronary events in treated hypertensive men. Clin Cardiol 25 (2002) 287-290
31. Luc G., Bard J.M., Arveiler D., et al. Lipoprotein (a) as a predictor of coronary heart disease: the PRIME Study. Atherosclerosis 163 (2002) 377-384
32. Ariyo A.A., Thach C., and Tracy R. Lp(a) lipoprotein, vascular disease, and mortality in the elderly. N Engl J Med 349 (2003) 2108